Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Cannara Biotech Inc banner
C

Cannara Biotech Inc
XTSX:LOVE

Watchlist Manager
Cannara Biotech Inc
XTSX:LOVE
Watchlist
Price: 1.82 CAD 1.11% Market Closed
Market Cap: CA$172.7m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

LOVE Price Targets Summary
Cannara Biotech Inc

Wall Street analysts forecast LOVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LOVE is 3.57 CAD with a low forecast of 3.54 CAD and a high forecast of 3.68 CAD.

LOVE Lowest Forecast
Wall Street Target
3.54 CAD
94% Upside
LOVE Average Forecast
Wall Street Target
3.57 CAD
96% Upside
LOVE Highest Forecast
Wall Street Target
3.68 CAD
102% Upside
Lowest
Price Target
3.54 CAD
94% Upside
Average
Price Target
3.57 CAD
96% Upside
Highest
Price Target
3.68 CAD
102% Upside
Cannara Biotech Inc Competitors:
Price Targets

Revenue
Forecast

93% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
93% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 6 years the compound annual growth rate for Cannara Biotech Inc's revenue is 93%. The projected CAGR for the next 2 years is 14%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of Cannara Biotech Inc's net income for the next 2 years is 22%.

What are analyst estimates?

See Also

Summary
LOVE intrinsic value, competitors valuation, and company profile.
DCF Valuation
LOVE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LOVE stock valuation using valuation multiples.
Wall Street Estimates
LOVE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LOVE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LOVE's stock price target?
Price Target
3.57 CAD

According to Wall Street analysts, the average 1-year price target for LOVE is 3.57 CAD with a low forecast of 3.54 CAD and a high forecast of 3.68 CAD.

What is Cannara Biotech Inc's Revenue forecast?
Projected CAGR
14%

For the last 6 years the compound annual growth rate for Cannara Biotech Inc's revenue is 93%. The projected CAGR for the next 2 years is 14%.

What is Cannara Biotech Inc's Net Income forecast?
Projected CAGR
22%

The compound annual growth rate of Cannara Biotech Inc's net income for the next 2 years is 22%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 318,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.